Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

V. D'Amore, I. Santolini, C. M. Van Rijn, F. Biagioni, G. Molinaro, A. Prete, P. J. Conn, C. W. Lindsley, Y. Zhou, P. N. Vinson, A. L. Rodriguez, C. K. Jones, S. R. Stauffer, F. Nicoletti, G. Van Luijtelaar, R. T. Ngomba

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Absence epilepsy is generated by the cortico-thalamo-cortical network, which undergoes a finely tuned regulation by metabotropic glutamate (mGlu) receptors. We have shown previously that potentiation of mGlu1 receptors reduces spontaneous occurring spike and wave discharges (SWDs) in the WAG/Rij rat model of absence epilepsy, whereas activation of mGlu2/3 and mGlu4 receptors produces the opposite effect. Here, we have extended the study to mGlu5 receptors, which are known to be highly expressed within the cortico-thalamo-cortical network. We used presymptomatic and symptomatic WAG/Rij rats and aged-matched ACI rats. WAG/Rij rats showed a reduction in the mGlu5 receptor protein levels and in the mGlu5-receptor mediated stimulation of polyphosphoinositide hydrolysis in the ventrobasal thalamus, whereas the expression of mGlu5 receptors was increased in the somatosensory cortex. Interestingly, these changes preceded the onset of the epileptic phenotype, being already visible in pre-symptomatic WAG/Rij rats. SWDs in symptomatic WAG/Rij rats were not influenced by pharmacological blockade of mGlu5 receptors with MTEP (10 or 30 mg/kg, i.p.), but were significantly decreased by mGlu5 receptor potentiation with the novel enhancer, VU0360172 (3 or 10 mg/kg, s.c.), without affecting motor behaviour. The effect of VU0360172 was prevented by co-treatment with MTEP. These findings suggest that changes in mGlu5 receptors might lie at the core of the absence-seizure prone phenotype of WAG/Rij rats, and that mGlu5 receptor enhancers are potential candidates to the treatment of absence epilepsy. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.

Original languageEnglish (US)
Pages (from-to)330-338
Number of pages9
JournalNeuropharmacology
Volume66
DOIs
StatePublished - Mar 1 2013

Fingerprint

Absence Epilepsy
Metabotropic Glutamate Receptors
Inbred ACI Rats
Phenotype
Phosphatidylinositol Phosphates
Somatosensory Cortex
Thalamus
N-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide
Hydrolysis
Pharmacology
Proteins

Keywords

  • Absence epilepsy
  • mGlu5 receptor
  • MTEP
  • VU0360172
  • WAG/Rij rats

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats. / D'Amore, V.; Santolini, I.; Van Rijn, C. M.; Biagioni, F.; Molinaro, G.; Prete, A.; Conn, P. J.; Lindsley, C. W.; Zhou, Y.; Vinson, P. N.; Rodriguez, A. L.; Jones, C. K.; Stauffer, S. R.; Nicoletti, F.; Van Luijtelaar, G.; Ngomba, R. T.

In: Neuropharmacology, Vol. 66, 01.03.2013, p. 330-338.

Research output: Contribution to journalArticle

D'Amore, V, Santolini, I, Van Rijn, CM, Biagioni, F, Molinaro, G, Prete, A, Conn, PJ, Lindsley, CW, Zhou, Y, Vinson, PN, Rodriguez, AL, Jones, CK, Stauffer, SR, Nicoletti, F, Van Luijtelaar, G & Ngomba, RT 2013, 'Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats', Neuropharmacology, vol. 66, pp. 330-338. https://doi.org/10.1016/j.neuropharm.2012.05.044
D'Amore, V. ; Santolini, I. ; Van Rijn, C. M. ; Biagioni, F. ; Molinaro, G. ; Prete, A. ; Conn, P. J. ; Lindsley, C. W. ; Zhou, Y. ; Vinson, P. N. ; Rodriguez, A. L. ; Jones, C. K. ; Stauffer, S. R. ; Nicoletti, F. ; Van Luijtelaar, G. ; Ngomba, R. T. / Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats. In: Neuropharmacology. 2013 ; Vol. 66. pp. 330-338.
@article{cf6b5b1e54264604a8fa87bbedbcfecf,
title = "Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats",
abstract = "Absence epilepsy is generated by the cortico-thalamo-cortical network, which undergoes a finely tuned regulation by metabotropic glutamate (mGlu) receptors. We have shown previously that potentiation of mGlu1 receptors reduces spontaneous occurring spike and wave discharges (SWDs) in the WAG/Rij rat model of absence epilepsy, whereas activation of mGlu2/3 and mGlu4 receptors produces the opposite effect. Here, we have extended the study to mGlu5 receptors, which are known to be highly expressed within the cortico-thalamo-cortical network. We used presymptomatic and symptomatic WAG/Rij rats and aged-matched ACI rats. WAG/Rij rats showed a reduction in the mGlu5 receptor protein levels and in the mGlu5-receptor mediated stimulation of polyphosphoinositide hydrolysis in the ventrobasal thalamus, whereas the expression of mGlu5 receptors was increased in the somatosensory cortex. Interestingly, these changes preceded the onset of the epileptic phenotype, being already visible in pre-symptomatic WAG/Rij rats. SWDs in symptomatic WAG/Rij rats were not influenced by pharmacological blockade of mGlu5 receptors with MTEP (10 or 30 mg/kg, i.p.), but were significantly decreased by mGlu5 receptor potentiation with the novel enhancer, VU0360172 (3 or 10 mg/kg, s.c.), without affecting motor behaviour. The effect of VU0360172 was prevented by co-treatment with MTEP. These findings suggest that changes in mGlu5 receptors might lie at the core of the absence-seizure prone phenotype of WAG/Rij rats, and that mGlu5 receptor enhancers are potential candidates to the treatment of absence epilepsy. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.",
keywords = "Absence epilepsy, mGlu5 receptor, MTEP, VU0360172, WAG/Rij rats",
author = "V. D'Amore and I. Santolini and {Van Rijn}, {C. M.} and F. Biagioni and G. Molinaro and A. Prete and Conn, {P. J.} and Lindsley, {C. W.} and Y. Zhou and Vinson, {P. N.} and Rodriguez, {A. L.} and Jones, {C. K.} and Stauffer, {S. R.} and F. Nicoletti and {Van Luijtelaar}, G. and Ngomba, {R. T.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.neuropharm.2012.05.044",
language = "English (US)",
volume = "66",
pages = "330--338",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

AU - D'Amore, V.

AU - Santolini, I.

AU - Van Rijn, C. M.

AU - Biagioni, F.

AU - Molinaro, G.

AU - Prete, A.

AU - Conn, P. J.

AU - Lindsley, C. W.

AU - Zhou, Y.

AU - Vinson, P. N.

AU - Rodriguez, A. L.

AU - Jones, C. K.

AU - Stauffer, S. R.

AU - Nicoletti, F.

AU - Van Luijtelaar, G.

AU - Ngomba, R. T.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Absence epilepsy is generated by the cortico-thalamo-cortical network, which undergoes a finely tuned regulation by metabotropic glutamate (mGlu) receptors. We have shown previously that potentiation of mGlu1 receptors reduces spontaneous occurring spike and wave discharges (SWDs) in the WAG/Rij rat model of absence epilepsy, whereas activation of mGlu2/3 and mGlu4 receptors produces the opposite effect. Here, we have extended the study to mGlu5 receptors, which are known to be highly expressed within the cortico-thalamo-cortical network. We used presymptomatic and symptomatic WAG/Rij rats and aged-matched ACI rats. WAG/Rij rats showed a reduction in the mGlu5 receptor protein levels and in the mGlu5-receptor mediated stimulation of polyphosphoinositide hydrolysis in the ventrobasal thalamus, whereas the expression of mGlu5 receptors was increased in the somatosensory cortex. Interestingly, these changes preceded the onset of the epileptic phenotype, being already visible in pre-symptomatic WAG/Rij rats. SWDs in symptomatic WAG/Rij rats were not influenced by pharmacological blockade of mGlu5 receptors with MTEP (10 or 30 mg/kg, i.p.), but were significantly decreased by mGlu5 receptor potentiation with the novel enhancer, VU0360172 (3 or 10 mg/kg, s.c.), without affecting motor behaviour. The effect of VU0360172 was prevented by co-treatment with MTEP. These findings suggest that changes in mGlu5 receptors might lie at the core of the absence-seizure prone phenotype of WAG/Rij rats, and that mGlu5 receptor enhancers are potential candidates to the treatment of absence epilepsy. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.

AB - Absence epilepsy is generated by the cortico-thalamo-cortical network, which undergoes a finely tuned regulation by metabotropic glutamate (mGlu) receptors. We have shown previously that potentiation of mGlu1 receptors reduces spontaneous occurring spike and wave discharges (SWDs) in the WAG/Rij rat model of absence epilepsy, whereas activation of mGlu2/3 and mGlu4 receptors produces the opposite effect. Here, we have extended the study to mGlu5 receptors, which are known to be highly expressed within the cortico-thalamo-cortical network. We used presymptomatic and symptomatic WAG/Rij rats and aged-matched ACI rats. WAG/Rij rats showed a reduction in the mGlu5 receptor protein levels and in the mGlu5-receptor mediated stimulation of polyphosphoinositide hydrolysis in the ventrobasal thalamus, whereas the expression of mGlu5 receptors was increased in the somatosensory cortex. Interestingly, these changes preceded the onset of the epileptic phenotype, being already visible in pre-symptomatic WAG/Rij rats. SWDs in symptomatic WAG/Rij rats were not influenced by pharmacological blockade of mGlu5 receptors with MTEP (10 or 30 mg/kg, i.p.), but were significantly decreased by mGlu5 receptor potentiation with the novel enhancer, VU0360172 (3 or 10 mg/kg, s.c.), without affecting motor behaviour. The effect of VU0360172 was prevented by co-treatment with MTEP. These findings suggest that changes in mGlu5 receptors might lie at the core of the absence-seizure prone phenotype of WAG/Rij rats, and that mGlu5 receptor enhancers are potential candidates to the treatment of absence epilepsy. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.

KW - Absence epilepsy

KW - mGlu5 receptor

KW - MTEP

KW - VU0360172

KW - WAG/Rij rats

UR - http://www.scopus.com/inward/record.url?scp=84872139189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872139189&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2012.05.044

DO - 10.1016/j.neuropharm.2012.05.044

M3 - Article

C2 - 22705340

AN - SCOPUS:84872139189

VL - 66

SP - 330

EP - 338

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -